Prochlorperazine Edisylate Injection
Product Images NDC 0713-0351

4 FDA label images from Cosette Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 0713-0351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10-count-carton-label-cosette (10 Count Carton Label Cosette 2)

10-count-carton-label-cosette (10 Count Carton Label Cosette 2)
Packaging label for Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) by Cosette Pharmaceuticals, Inc. The label indicates use for deep intramuscular or intravenous injection only, not for subcutaneous use. It contains ten 2 mL multiple-dose vials. The label includes storage instructions, manufacturing by Maiva Pharma Private Limited in India, and a barcode with NDC 0713-0351-09.*
FDA Label Image

25-count-carton-label-cosette (25 Count Carton Label Cosette)

25-count-carton-label-cosette (25 Count Carton Label Cosette)
Packaging label for Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) by Cosette Pharmaceuticals, Inc. The label states it is for intramuscular or intravenous use only, not for subcutaneous use. The package contains twenty-five 2 mL multiple-dose vials. The label includes storage instructions, dosage information, manufacturer details (Msava Pharma Private Limited, India), and a barcode.*
FDA Label Image

Chemical Structure (Chemical Structure)

Chemical Structure (Chemical Structure)
Chemical structure of prochlorperazine edisylate, showing its molecular components including a piperazine ring, chlorinated phenothiazine core, and sulfonic acid groups associated with the edisylate salt form.*
FDA Label Image

Vial-label-cosette (Vial Label Cosette 2)

Vial-label-cosette (Vial Label Cosette 2)
Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) vial label. For deep intramuscular or intravenous use only, not for subcutaneous use. Distributed by Cosette Pharmaceuticals, Inc., South Plainfield, NJ. Made in India. Features NDC 0713-0351-02 and multiple-dose vial indication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.